Infinant Health
Sacramento, US · Delaware corporation · 7 known investors
Find your way into Infinant Health
248 people in our graph share verified history with the Infinant Health team — schools, employers, funds. One of them is your warm intro.
Charles Callunlockedknows David Mills · together at Montana State University-Bozeman (overlapped)
×4knows the team · via University of California, Davis
×3knows the team · via University of Wisconsin-Madison
knows the team · via University of Minnesota
×3knows the team · via Montana State University-Bozeman
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.
Founders & leadership
JB
J. Bruce GermanCo-founder
DM
David Millsin𝕏Co-founderDavid Mills is a Distinguished Professor of Food Science & Technology at UC Davis whose research focuses on the molecular biology and ecology of gut bacteria and bacterial genomics. He co-founded Infinant Health, which develops probiotic therapeutics based on B. infantis strains for infant microbiome health.
CL
Carlito LebrillaCo-founder
DB
Daniela BarileCo-founder
SF
Samara FreemaninCo-founder & Director of Intellectual Property and Regulatory Affairs
MJ
Michael JohnsonExecutive
Board
LS
Laura StoppelBoard director
ML
Mike LiangBoard director
AB
Amanda Birdsey-BensonBoard director
RW
PE
KK
Katharine KnobilBoard director
Investors · 7
Acre Venture PartnersSanta Monica · $100K – $10M
Bow CapitalMenlo Park
Horizons VenturesHong Kong · $1M – $110M
iSelect FundSt. Louis · $250K – $2M
Longitude CapitalMenlo Park · $10M – $30M
Bill & Melinda Gates FoundationreportedSeattle
Spruce Capital PartnersreportedSouth San Franciscovia Roger Wyse · board
Reported raises · per SEC filings
Form D private placements$39.2M disclosed across 1 round · 2026
▶$39.2MraisedJun 2026 · 29 investors · Other Health CareRule 506(b)
▶$39.2MraisedJun 2026 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
- Laura StoppelDirector
- Michael JohnsonExecutive Officer, Director
- Mike LiangDirector
- Amanda Birdsey-BensonDirector
- Roger WyseDirector
- Patrick EnrightDirector
- Katharine KnobilDirector
- Offering amount
- $118.2M
- Amount sold
- $39.2M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Infinant Health went on to found or lead other companies.
Competitors · 5
by search overlap
Guardant Health17 shared keywordsGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
Immunovant15 shared keywordsImmunovant is a clinical-stage immunology company developing targeted therapies based on anti-FcRn technology for people with autoimmune diseases.
Signant Health15 shared keywordsSignant Health provides software platforms and clinical trial solutions for life sciences companies to manage patient-reported outcomes, evidence generation, and digital endpoints in drug development programs across multiple therapeutic areas.
Octant Bio11 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Startup Health10 shared keywordsStartUp Health operates a private global membership community for health innovators — including founders, healthcare executives, investors, and clinicians — offering a member network app, live AMAs and fireside chats, in-person event access, and a content library. It focuses on connecting and supporting people working on digital health and healthcare innovation.
Companies competing with Infinant Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Infinant Health do?
- Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.
- Who founded Infinant Health?
- Infinant Health was founded by J. Bruce German, David Mills, Carlito Lebrilla, Daniela Barile, Samara Freeman.
- Who are Infinant Health's investors?
- Infinant Health's investors include Acre Venture Partners, Bow Capital, Horizons Ventures, iSelect Fund, Longitude Capital, Bill & Melinda Gates Foundation, Spruce Capital Partners.
- How much funding has Infinant Health raised?
- Infinant Health has disclosed $39.2M raised across 1 round.
- Where is Infinant Health headquartered?
- Infinant Health is headquartered in Sacramento, US.